MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Semiquantitative analyses of DAT-SPECT imaging with an automated striatal analysis software in differential diagnosis of neurodegenerative parkinsonism

    N. Morimoto, M. Takamiya, M. Morimoto (Takamatsu, Japan)

    Objective: We investigate the usefulness Dopamine transporter (DAT)-SPECT with an automated striatal analysis software in differential diagnosis of neurodegenerative parkinsonism. Background: DAT-SPECT imaging is sensitive…
  • 2017 International Congress

    Are a „mathematical brain“ and early childhood adverse events possible risk factors that contribute to Progressive Supranuclear Palsy?

    S. Lorenzl (Hausham, Germany)

    Objective: To evaluate possible risk factors for the development of Progressive Supranuclear Palsy (PSP). Background: Risk factors for the development of neurodegenerative brain disorders are…
  • 2017 International Congress

    Metabolomics study in a group of Parkinson’s disease patients from Northern India

    G.N. Babu, M. Gupta, V.K. Paliwal, S. Singh, R. Roy (Lucknow, India)

    Objective: To do (1) H NMR study in a group of Parkinson’s disease patients, disease controls, viz. multiple system atrophy (MSA) and progressive supra nuclear…
  • 2017 International Congress

    Neurogenic bladder in progressive supranuclear palsy: A comparison with Parkinson’s disease and multiple system atrophy

    K.J. Kim, J.-M. Kim (Seongnam-Si, Republic of Korea)

    Objective: To compare the features of urinary dysfunction in Progressive supranuclear palsy (PSP) with those of idiopathic Parkinson’s disease (IPD) and multiple system atrophy (MSA). Background:…
  • 2017 International Congress

    Rolipram, a PDE-IV inhibitor protects against experimental Parkinsonism in mice

    N. KUMAR, R. Khanna (Jaipur, India)

    Objective: Rolipram, a specific inhibitor of the phosphodiesterase IV (PDE IV), has recently been shown to exert neuroprotective effects in an Alzheimer transgenic mouse model…
  • 2017 International Congress

    Neuropsychiatric and Cognitive Predictors of Early Diagnosis of Progressive Supranuclear Palsy

    C. Pellicano, F. Assogna, N. Cellupica, M. Pierantozzi, A. Stefani, R. Cerroni, B. Mercuri, C. Caltagirone, F. Pontieri, G. Spalletta (Rome, Italy)

    Objective: To define differences of neuropsychiatric and neuropsychological profile among Progressive Supranuclear Palsy (PSP) -Richardson syndrome (PSP-RS), PSP-parkinsonism (PSP-P), and Parkinson’s disease (PD), in order…
  • 2017 International Congress

    Anatomical predictors of survival in PSP: thalamic collapse towards the end of life

    W. Bevan-Jones, S. Jones, B. Ghosh, T. Rittman, I. Coyle-Gilchrist, J. Rowe (Cambridge, United Kingdom)

    Objective: To correlate anatomical changes with time to death in PSP. Background: Many advances have been made in progressive supranuclear palsy (PSP) since it was first described…
  • 2017 International Congress

    Long-term Parkinson’s disease progression in PIGD and TD subtypes in the PPMI cohort

    D. Aleksovski, D. Miljkovic, A. Antonini (Ljubljana, Slovenia)

    Objective: Analyze the disease progression and time of therapy initiation for tremor dominant (TD) and postural instability gait disorder (PIGD) subtypes in the PPMI cohort.…
  • 2017 International Congress

    Clinicopathological analysis of corticobasal syndrome: a retrospective study

    R. Lamb, J. Rohrer, R. Weil, H. Ling, A. Lees, H. Morris (London, United Kingdom)

    Objective: Predicting underlying pathology in CBS. Background: Corticobasal syndrome (CBS) is pathologically heterogeneous.  CBS is one of the clinical phenotypes of corticobasal degeneration (CBD) but may…
  • 2017 International Congress

    Secondary Vascular Parkinsonism in Uzbekistan: Hormonal Pathogenetic Effects and Vascular-Immunological Basics.

    D. Akramova (Tashkent, Uzbekistan)

    Objective: We aimed to analyze the PD related hormonal factors and VP hormonal endothelial factors. Background: As we know the Vascular Parkinsonism (VP) and Symptomatic…
  • « Previous Page
  • 1
  • …
  • 1602
  • 1603
  • 1604
  • 1605
  • 1606
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley